Lasa Supergenerics Limited (BOM:540702)
India · Delayed Price · Currency is INR 7.60
-0.01 (-0.13%)
At close: Apr 13, 2026
Lasa Supergenerics Market Cap
Lasa Supergenerics has a market cap or net worth of 381.77 million as of April 15, 2026. Its market cap has decreased by -61.34% in one year.
Market Cap
381.77M
Enterprise Value
448.19M
Revenue
669.61M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.60
Market Cap Chart
Since September 22, 2017, Lasa Supergenerics's market cap has decreased from 3.53B to 381.77M, a decrease of -89.20%. That is a compound annual growth rate of -22.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 381.77M | -19.28% |
| Dec 31, 2025 | 472.96M | -62.89% |
| Dec 31, 2024 | 1.27B | -14.92% |
| Dec 29, 2023 | 1.50B | 9.45% |
| Dec 30, 2022 | 1.37B | -50.95% |
| Dec 31, 2021 | 2.79B | -18.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 22, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Smruthi Organics | 1.26B |
| Tyche Industries | 1.24B |
| Resonance Specialties | 1.07B |
| Bacil Pharma | 818.98M |
| Alfavision Overseas (India) | 481.72M |
| Vasundhara Rasayans | 402.52M |
| Venmax Drugs and Pharmaceuticals | 295.36M |
| Crestchem | 276.60M |